Study on the colonization mechanism of probiotics in human gut

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2200057145

Enrollment

Unknown

Registered

2022-03-01

Start date

2022-02-25

Completion date

Unknown

Last updated

2023-10-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None

Interventions

Bifidobacterium breve CCFM1025 group:Daily oral intake of one packet of probiotics (1x10^10 CFU)

Bifidobacterium breve FHLJDQ3M5 group:Daily oral intake of one packet of probiotics (1x10^10 CFU)

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. No gender or race limitation; 2. Aged 18-65 years; 3. Did not use any drugs affecting gastrointestinal motility in the past week; 4. Good compliance, able to comply with the requirements of clinical trials; 5. The subject or guardian has signed the informed consent; 6. Subjects filled in written informed consent, basic information questionnaire, dietary structure and living condition questionnaire, and promised to cooperate with the study during the whole trial period.

Exclusion criteria

Exclusion criteria: 1. Ingestion history of other probiotics and related products within 4 weeks; 2. History of antibiotic intake within 8 weeks; 3. Chronic laxative abuse; 4. Allergic or intolerant to the ingredients of the test probiotic products.

Design outcomes

Primary

Measure	Time frame
Colonization amount of strain;	—

Countries

China

Contacts

Public ContactWang Gang

Jiangnan University

wanggang@jiangnan.edu.cn+86 15852818722

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026